IRulya Therapeutics, Inc. (IRLA)
38.28
-1.50
(-3.77%)
USD |
NASDAQ |
Nov 13, 10:26
IRulya Therapeutics Free Cash Flow (Quarterly) : -18.89M for June 30, 2026
Free Cash Flow (Quarterly) Chart
Historical Free Cash Flow (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -18.89M |
| March 31, 2026 | -7.627M |
| December 31, 2025 | -10.48M |
| September 30, 2025 | -10.00M |
| June 30, 2025 | -11.54M |
| March 31, 2025 | -9.749M |
| December 31, 2024 | -7.685M |
| September 30, 2024 | -7.306M |
| June 30, 2024 | -8.778M |
| March 31, 2024 | -8.392M |
| December 31, 2023 | -6.102M |
| September 30, 2023 | -4.818M |
| June 30, 2023 | -3.827M |
| March 31, 2023 | -3.705M |
| December 31, 2022 | -5.913M |
| September 30, 2022 | -6.747M |
| Date | Value |
|---|---|
| June 30, 2022 | -15.42M |
| March 31, 2022 | -16.10M |
| December 31, 2021 | -14.46M |
| September 30, 2021 | -17.34M |
| June 30, 2021 | -17.66M |
| March 31, 2021 | -13.65M |
| December 31, 2020 | -13.29M |
| September 30, 2020 | -12.39M |
| June 30, 2020 | -14.41M |
| March 31, 2020 | -10.78M |
| December 31, 2019 | -10.96M |
| September 30, 2019 | -8.822M |
| June 30, 2019 | -6.284M |
| March 31, 2019 | -7.267M |
| June 30, 2018 | -2.634M |
| March 31, 2018 | -3.177M |
Free Cash Flow Definition
Free Cash Flow is the cash a company has left after paying for its day-to-day operations and investing in its physical assets, such as buildings, equipment and technology. The company can use that cash however it chooses: paying dividends, buying back shares, paying down debt, making acquisitions or keeping it for future growth.
Free Cash Flow (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow (Quarterly) Benchmarks
| Korsana Biosciences, Inc. | -47.06M |
| PepGen Inc. | -13.18M |
| Q32 Bio, Inc. | -4.47M |
| Bridgebio Oncology Therapeutics, Inc. | -28.38M |
| Arrowhead Pharmaceuticals, Inc. | -181.32M |